Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.
Nashan B, Suwelack B, Ivens K, Arns W, Lhotta K, Bourbigot B, Budde K, Fischer W, Pietruck F; ERL2405-DE02 Study Group. Nashan B, et al. Among authors: pietruck f. Transplant Proc. 2006 Nov;38(9):2856-9. doi: 10.1016/j.transproceed.2006.08.118. Transplant Proc. 2006. PMID: 17112848 Clinical Trial.
Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
Kliem V, Fritsche L, Haller H, Suwelack B, Abendroth D, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U, Ulbricht B; International MOST Study Group. Kliem V, et al. Among authors: pietruck f. Transplant Proc. 2005 Apr;37(3):1597-600. doi: 10.1016/j.transproceed.2004.09.017. Transplant Proc. 2005. PMID: 15866683
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U, Kramer S, Fischer W, Gschaidmeier H, Pietruck F; ZEUS Study Investigators. Budde K, et al. Among authors: pietruck f. Lancet. 2011 Mar 5;377(9768):837-47. doi: 10.1016/S0140-6736(10)62318-5. Epub 2011 Feb 19. Lancet. 2011. PMID: 21334736 Clinical Trial.
Bone disease after renal transplantation.
Kunzendorf U, Krämer BK, Arns W, Braun J, Grossmann J, Pietruck F, Schmidt-Gayk H, Schwarz A, Ziegler E, Sperschneider H, Wüthrich RP, Nonnast-Daniel B, Schindler R, Renders L. Kunzendorf U, et al. Among authors: pietruck f. Nephrol Dial Transplant. 2008 Feb;23(2):450-8. doi: 10.1093/ndt/gfm816. Epub 2007 Dec 1. Nephrol Dial Transplant. 2008. PMID: 18056071 Free article. Review. No abstract available.
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K. Krämer BK, et al. Among authors: pietruck f. Transplantation. 2012 Sep 15;94(5):492-8. doi: 10.1097/TP.0b013e31825c1d6c. Transplantation. 2012. PMID: 22858806 Free article. Clinical Trial.
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.
Krämer BK, Klinger M, Wlodarczyk Z, Ostrowski M, Midvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Vítko S, Senatorski G, Salmela K, Nordström J. Krämer BK, et al. Among authors: pietruck f. Clin Transplant. 2010 Jan-Feb;24(1):E1-9. doi: 10.1111/j.1399-0012.2009.01162.x. Epub 2009 Nov 18. Clin Transplant. 2010. PMID: 19925464 Clinical Trial.
44 results